date:May 15, 2014
ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced the initiation of the second human clinical study for PURENERGY, its patented caffeine ingredient.
The Institutional Review Board (IRB)-approved, crossover design study will be administered by Medicus Research and will build on the results from the first PURENERGY h